Watson, G. A., Sanz-Garcia, E., Zhang, W., Liu, Z. A., Yang, S. C., Wang, B., Liu, S., Kubli, S., Berman, H., Pfister, T., Genta, S., Spreafico, A., Hansen, A. R., Bedard, P. L., Lheureux, S., Abdul Razak, A., Cescon, D., Butler, M. O., Xu, W., Mak, T. W., Siu, L. L., & Chen, E. (2022). increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumab. Journal for immunotherapy of cancer, 10(6), . http://access.bl.uk/ark:/81055/vdc_100156720140.0x000005